62 filings from 2 registrants · 2008–2024 · latest filed Feb 3, 2025
Reported on its behalf
$677K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$677K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
James W RockRock & AssociatesCovered position: Staff Asst, US House Committee on Budget - 1985 to 200049 filingsthrough 2024
James RockParry, Romani, Deconcini & Symms18 filingsthrough 2013
Steve SymmsParry, Romani, Deconcini & Symms16 filingsthrough 2012
Romano RomaniParry, Romani, Deconcini & Symms16 filingsthrough 2012
Thaddeus E StromParry, Romani, Deconcini & Symms Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997
The filings
The 20 most recent of 62 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: braidwood-management-inc.
fees reported
›
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
43 filings
$479K on those filings
Law Enforcement/Crime/Criminal Justice
LAW
21 filings
$224K on those filings
Medical/Disease Research/Clinical Labs
MED
19 filings
$199K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
114th Congress
Saving Access to Compounded Medications for Special Needs Patients Act
H.R. 3018111th CongressNamed in the filings; no matching bill record on file.4 filingsthrough 2010
H.Con.Res. 342110th CongressExpressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.4 filingsthrough 2008
S.Con.Res. 88110th CongressA concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.4 filingsthrough 2008
H.R. 5054114th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20173 filingsthrough 2016
S. 2956114th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20173 filingsthrough 2016
H.R. 4800113th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20153 filingsthrough 2014
S. 2437113th CongressCommerce, Justice, Science, and Related Agencies Appropriations Act, 20153 filingsthrough 2014
S. 959113th CongressPharmaceutical Quality, Security, and Accountability Act3 filingsthrough 2013
H.R. 3089113th CongressCompounding Clarity Act of 20132 filingsthrough 2013
H.R. 3204113th CongressDrug Quality and Security Act2 filingsthrough 2013
H.R. 6584112th CongressVerifying Authority and Legality In Drug Compounding Act of 20121 filingthrough 2012
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Covered position:
11 filingsthrough 2011
Edward H BaxterParry, Romani, Deconcini & SymmsCovered position: Committee's Subcommittee on Patents, Copyrightsand Trademarks: 1987 to 19908 filingsthrough 2012
Dennis DeconciniParry, Romani, Deconcini & SymmsCovered position: U.S. Senator, 1977 to 19956 filingsthrough 2009
Covered positions · 4 of 7 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
